Dialysis Treatment Is an Independent Risk Factor for Foot Ulceration in Patients With Diabetes and Stage 4 or 5 Chronic Kidney Disease

被引:117
|
作者
Ndip, Agbor [1 ,2 ]
Rutter, Martin K. [1 ,2 ]
Vileikyte, Loretta [1 ,2 ]
Vardhan, Anand [3 ]
Asari, Ashwinbhai [3 ]
Jameel, Mehreen [4 ]
Tahir, Hassan A. [4 ]
Lavery, Lawrence A. [5 ,6 ]
Boulton, Andrew J. M. [1 ,2 ]
机构
[1] Cent Manchester Univ Hosp NHS Fdn Trust, Hlth Res Biomed Res Ctr, Manchester Diabet Ctr,Manchester Natl Inst, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[2] Univ Manchester, Sch Biomed, Cardiovasc Med Res Grp, Manchester, Lancs, England
[3] Manchester Royal Infirm, Dept Renal Serv, Manchester M13 9WL, Lancs, England
[4] Univ Manchester, Fac Med & Human Sci, Sch Med, Manchester, Lancs, England
[5] Texas A&M Hlth Sci Ctr, Dept Surg, Coll Med, Temple, TX USA
[6] Scott & White Hosp, Temple, TX USA
基金
美国国家卫生研究院;
关键词
LOWER-EXTREMITY AMPUTATION; PERIPHERAL ARTERIAL-DISEASE; NONDIABETIC SUBJECTS; RENAL-INSUFFICIENCY; ASSOCIATION; MELLITUS; ULCERS; POPULATION; PREVALENCE; HEART;
D O I
10.2337/dc10-0255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine whether dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and renal impairment. RESEARCH DESIGN AND METHODS We performed a cross-sectional study of consecutive patients with diabetes and stage 4 or 5 chronic kidney disease (CKD) attending clinics in Manchester (U.K.). Patients were classified as either receiving dialysis therapy (dialysis) or not (no dialysis). Foot assessment included diabetic peripheral neuropathy (DPN), peripheral arterial disease (PAD), prior foot ulceration and amputation, and foot self-care. Risk factors for prevalent foot ulceration were assessed by logistic regression. RESULTS We studied 326 patients with diabetes and CKD (mean age 64 years; 61% male; 78% type 2 diabetes; 11% prevalent foot ulceration). Compared with no dialysis patients, dialysis patients had a higher prevalence of DPN (79 vs. 65%), PAD (64 vs. 43%), prior amputations (15 vs. 6.4%), prior foot ulceration (32 vs. 20%), and prevalent foot ulceration (21 vs. 5%, all P < 0.05). In univariate analyses, foot ulceration was related to wearing bespoke footwear (odds ratio 5.6 [95% Cl 2.5-13]) dialysis treatment (5.1 [2.3-11]), prior foot ulceration (4.8 [2.3-9.8], PAD (2.8 [1.3-6.0], and years of diabetes (1.0 [1.0-1.1], all P < 0.01). In multivariate logistic regression, only dialysis treatment (4.2 [1.7-10], P = 0.002) and prior foot ulceration (3.1 [1.3-7.1], P = 0.008) were associated with prevalent foot ulceration. CONCLUSIONS Dialysis treatment was independently associated with foot ulceration. Guidelines should highlight dialysis as an important risk factor for foot ulceration requiring intensive foot care.
引用
收藏
页码:1811 / 1816
页数:6
相关论文
共 50 条
  • [31] Serum Uric Acid, the Metabolic Syndrome, and the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes
    Sheikhbahaei, Sara
    Fotouhi, Akbar
    Hafezi-Nejad, Nima
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    METABOLIC SYNDROME AND RELATED DISORDERS, 2014, 12 (02) : 102 - 109
  • [32] Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications
    Calo, Lorenzo A.
    Vertolli, Ugo
    Pagnin, Elisa
    Ravarotto, Verdiana
    Davis, Paul A.
    Lupia, Mario
    Naso, Elena
    Maiolino, Giuseppe
    Naso, Agostino
    LIFE SCIENCES, 2016, 148 : 80 - 85
  • [33] Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
    Provenzano, Michele
    Minutolo, Roberto
    Chiodini, Paolo
    Bellizzi, Vincenzo
    Nappi, Felice
    Russo, Domenico
    Borrelli, Silvio
    Garofalo, Carlo
    Iodice, Carmela
    De Stefano, Toni
    Conte, Giuseppe
    Heerspink, Hiddo J. L.
    De Nicola, Luca
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [34] Clinical assessment and treatment of diabetes in patients with chronic kidney disease
    Carretero Gomez, J.
    Arevalo Lorido, J. C.
    REVISTA CLINICA ESPANOLA, 2018, 218 (06): : 305 - 315
  • [35] Upper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan
    Liang, Chih-Chia
    Chou, Che-Yi
    Chang, Chiz-Tzung
    Wang, I-Kuan
    Huang, Chiu-Ching
    BMJ OPEN, 2016, 6 (05):
  • [36] Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis
    Kim, Sang-Hyon
    Lee, So-Yeon
    Kim, Ji-Min
    Son, Chang-Nam
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (04) : 998 - 1003
  • [37] Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation
    Jagdale, Abhijit
    Cooper, David K. C.
    Iwase, Hayato
    Gaston, Robert S.
    XENOTRANSPLANTATION, 2019, 26 (02)
  • [38] Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
    Minutolo, Roberto
    Garofalo, Carlo
    Chiodini, Paolo
    Aucella, Filippo
    Del Vecchio, Lucia
    Locatelli, Francesco
    Scaglione, Francesco
    De Nicola, Luca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (02) : 267 - 274
  • [39] Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes
    Ao, Yang
    Ye, Hao
    Liu, Xiaohui
    Li, Yin
    Liu, Haoyin
    Ye, Shu
    Hu, Yepeng
    Zhuang, Pan
    Zhang, Yu
    Zheng, Chao
    Jiao, Jingjing
    DIABETES OBESITY & METABOLISM, 2024, 26 (11) : 5283 - 5292
  • [40] Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1-4 patients
    Yuan, Qiongjing
    Xie, Yanyun
    Peng, Zhangzhe
    Wang, Jinwei
    Zhou, Qiaoling
    Xiao, Xiangcheng
    Wang, Wei
    Huang, Ling
    Tang, Wenbin
    Li, Xiaozhao
    Zhang, Luxia
    Wang, Fang
    Zhao, Ming-Hui
    Tao, Lijian
    He, Kevin
    Wanggou, Siyi
    Xu, Hui
    CLINICAL NUTRITION, 2021, 40 (04) : 2394 - 2400